End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,760 KRW | +0.11% | -39.67% | -23.49% |
Mar. 22 | HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8% | MT |
Mar. 21 | HLB Life Science Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 110
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Distribution
64.7
%
| 54,058 | 54.3 % | 63,412 | 64.7 % | +17.30% |
Medicare
29.4
%
| 34,707 | 34.8 % | 28,802 | 29.4 % | -17.01% |
Others
4.5
%
| 4,810 | 4.8 % | 4,413 | 4.5 % | -8.26% |
Construction and Engineering
1.4
%
| 5,886 | 5.9 % | 1,362 | 1.4 % | -76.86% |
Bio Development
0.0
%
| 130 | 0.1 % | 1 | 0.0 % | -99.12% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
99.6
%
| 99,484 | 99.9 % | 97,630 | 99.6 % | -1.86% |
Overseas
0.4
%
| 107 | 0.1 % | 361 | 0.4 % | +236.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sang-Woo Nam
CEO | Chief Executive Officer | 66 | - |
Yang-Gon Jin
CEO | Chief Executive Officer | 58 | 15-12-10 |
Ki-Hwan Kim
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Geun-Shik Lee
BRD | Director/Board Member | 51 | - |
Young-Hyun Kim
AUD | Comptroller/Controller/Auditor | 66 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yang-Gon Jin
CEO | Chief Executive Officer | 58 | 15-12-10 |
Sang-Woo Nam
CEO | Chief Executive Officer | 66 | - |
Yoon-Gi Baek
BRD | Director/Board Member | 61 | - |
In-Geun Jang
BRD | Director/Board Member | 48 | - |
Geun-Shik Lee
BRD | Director/Board Member | 51 | - |
Soo-Ja Choi
BRD | Director/Board Member | 59 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 107,644,871 | 87,926,274 ( 81.68 %) | 71,752 ( 0.0667 %) | 81.68 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
HLB CO., LTD. 2.05% | 2,681,798 | 2.05% | 215,770,173 $ |
HLB PHARMACEUTICAL CO., LTD. 13.61% | 4,322,044 | 13.61% | 106,636,063 $ |
HLB SCIENCE INC. 20.47% | 3,365,165 | 20.47% | 8,278,373 $ |
HLB INNOVATION CO.,LTD. 2.87% | 2,074,688 | 2.87% | 6,920,122 $ |
223,638 | 0.28% | 1,817,130 $ |
Company contact information
HLB Life Science Co., Ltd.
3-502, Pangyo Seven Venture Valley 1 15 Pangyo-ro 228beon-gil
13487, Seongnam-si
+
http://www.hlb-ls.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-23.49% | 690M | |
-4.44% | 23.46B | |
+4.89% | 8.59B | |
+7.83% | 8.35B | |
-21.35% | 7.88B | |
+14.84% | 5.21B | |
+10.84% | 4.09B | |
-1.97% | 4.11B | |
-0.41% | 3.87B | |
+20.72% | 3.6B |
- Stock Market
- Equities
- A067630 Stock
- Company HLB Life Science Co., Ltd.